Data protection Impressum

Medtech

Lausanne's CHUV has become the first hospital in Western Switzerland to deploy the Da Vinci Single Port robotic surgical assistant, performing minimally invasive procedures through a single 2.7 cm incision or a natural orifice across six surgical specialties.

CHUV deploys Western Switzerland’s first single-port robotic surgical assistant

29 April 2026

Three Geneva-based start-ups have received seed funding through the FONGIT Innovation Fund (FIF), supporting innovations in olfactory diagnostics, AI-powered maritime chartering, and SME cybersecurity.

Geneva backs three start-ups tackling smell, shipping, and cyber threats

27 April 2026

The applied research partnership between CSEM, the Insel Gruppe, and the University of Bern has been extended for three years, building on 32 medtech projects launched since 2023 and reinforcing Bern's ambition to become a leading international medical hub by 2030.

CSEM, Insel Gruppe, and University of Bern extend Bern medtech collaboration for three more years

20 April 2026

Lausanne-based AC Immune has amended its license and collaboration agreement with Eli Lilly to advance new Tau Morphomer small molecule candidates for Alzheimer's disease and other neurodegenerative diseases, with IND-enabling studies set to commence in the first half of 2026.

AC Immune secures CHF 10 million from Lilly to advance Alzheimer’s therapy

15 April 2026

Geneva-based dEEGtal has appointed neurotechnology entrepreneur and investor Ann Bunnenberg to its board of directors, as the AI-powered brain signal platform advances clinical studies across Switzerland, Spain, and the United States ahead of a CHF 4–5 million seed round.

dEEGtal strengthens governance and advances clinical validation across three continents

14 April 2026

Four life sciences projects were recognized at BIND – BioInnovation Day 2026, held at CHUV Lausanne on 1 April 2026, as the region's flagship academic innovation showcase drew 340 participants from academia, healthcare, industry, and investment.

BIND 2026 highlights Western Switzerland’s life sciences innovation pipeline

14 April 2026

Lausanne-based Polares Medical has closed an oversubscribed USD 50 million Series C financing round to advance clinical studies of its MRace Posterior Leaflet Replacement system for mitral regurgitation across the US, Europe, and Australia.

Polares Medical raises USD 50 million to advance its mitral valve replacement system

9 March 2026

As life sciences companies navigate increasingly complex global markets, the decision of where to establish or expand international operations has become a strategic one.

Why Life Sciences Companies Choose Switzerland to Scale Internationally

Renens-based L.E.S.S. SA has raised CHF 17 million to accelerate the industrial-scale deployment of its proprietary LuxiBright nano-fiber lighting technology across automotive, machine vision, and medical markets.

L.E.S.S. SA raises CHF 17 million to scale its nano-fiber lighting technology

3 March 2026

Bracco Imaging, Limula, and the University of Fribourg have launched an Innosuisse-funded research partnership to automate and reduce the cost of CAR-T cell therapy production.

Bracco, Limula and the University of Fribourg join forces to lower the cost of cell therapies

3 March 2026

1 2 3 4 5 6 … 15